Rocket Lab's Record Quarter Puts a Hard Number on the Neutron Dilemma
Published on 08/12/2026 at 17:42 | Redaktion boerse-global.de
The arithmetic of Rocket Lab's second quarter is easy to admire. Revenue hit $234.1 million, the order book swelled to a record $2.36 billion, and the company signed more than $1 billion in new contracts in the weeks after the period closed. The GAAP net loss narrowed to $49.3 million, or 8 cents a share, from $66.4 million a year earlier. By most operating metrics, this was the strongest quarter in the company's history.
And yet the stock fell roughly 10 percent in after-hours trading on Monday. The disconnect between the headline numbers and the market's reaction says less about the quarter itself than about what investors are now demanding from a company whose valuation has long been built on a promise that keeps sliding further into the future.
The immediate trigger was CEO Peter Beck's characterization of the launch window for the Neutron rocket as "tightening," language the market read as confirmation that the vehicle's debut is drifting from its original target of this quarter toward 2027. Rocket Lab now expects to bring Neutron to the launch pad in the fourth quarter of 2026, with the first flight itself receding beyond that. For a company whose equity story is so tightly wound around Neutron's potential to unlock higher-margin growth, each incremental delay carries a cost that no backlog figure can offset.
The selloff also had a more mechanical driver. The adjusted loss came in wider than analysts had modeled, and the pace of cash consumption — despite $2.13 billion in liquidity on hand — remains a persistent source of friction. Investors have effectively signaled that revenue records alone no longer suffice; the loss side of the ledger has to cooperate as well.
What makes the picture more complicated is that the demand environment has rarely looked better. In early August, the U.S. Space Force awarded Rocket Lab a $397 million contract under the SB-AMTI program to develop and operate multiple "Flatellite" spacecraft, which are themselves slated for Neutron launches. Days earlier, the company secured a $266 million deal for twelve suborbital missile-defense flights, with options for six more. Combined, the two government awards total more than $660 million and underscore Rocket Lab's standing as a strategic supplier to the Pentagon.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
The commercial side is adding fuel as well. On August 10, Kepler Communications signed up for a dedicated Neutron mission from Wallops Island, Virginia, with a launch date no earlier than 2028. The contract arrived just as management laid out third-quarter guidance of $250 million to $265 million in revenue, a GAAP gross margin between 29 and 31 percent, and an adjusted EBITDA loss of $17 million to $23 million.
Wall Street has largely chosen to look past the schedule slippage. On August 11, a wave of analysts reaffirmed or raised their targets: Cantor Fitzgerald's Andres Sheppard lifted his price objective to $122 and called Neutron the company's "most important catalyst" even with the timing risk. Bank of America's Ronald Epstein kept his Buy rating and $115 target, framing the post-earnings dip as an entry point given the record backlog. Needham, KeyBanc, Stifel, and Citizens JMP all landed in the $120-to-$135 range with Buy ratings, citing the growing order book and what they see as diminishing program risk.
The insider activity tells a slightly different story. On August 10, four company insiders — including President Marvin Clevenger, COO Frank Klein, and Chief Legal Officer Arjun Kampani — sold a combined 124,000 shares for roughly $18.4 million, mostly through automated 10b5-1 plans. The same day, Cathie Wood's ARK ETFs were buyers of Rocket Lab stock, trimming positions in Deere and Caterpillar to fund the purchases. A new institutional investor also disclosed a passive stake above 5 percent in late July.
The chart offers its own read on the tension. The stock closed Tuesday at $80.01, roughly flat on the day, and sits about 8 percent below its 50-day moving average of $87.16. It has more than doubled from the 52-week low of $37.57, yet remains roughly 47 percent below the springtime peak of $151.00. That gap captures the distance between the enthusiasm that drove the stock to record highs and the operational reality that has since unfolded.
Rocket Lab now finds itself at a juncture where two narratives run in parallel. One is the story of a defense and space supplier whose government relationships are deepening by the week, with a backlog that provides unusual visibility into future revenue. The other is the story of a company whose marquee growth project keeps slipping, whose losses are shrinking more slowly than the market would like, and whose cash burn remains a recurring question.
The record order book is a promise about the future. The Neutron delay and the cash consumption are the bill that comes due today. For now, the market is still weighing which one matters more — and the after-hours reaction suggests the answer is not yet settled.
Ad
Rocket Lab USA Stock: New Analysis - 12 August
Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
